Diabetes
  

Diabetes Medication Guide
 
Oral Hypoglycemic Medications:
Brand Name Generic Name Drug Category/Class Purposes
Diabeta, Glynase,
Micronase		 Glyburide Sulfonylureas 2nd generation

Increases insulin production in the pancreas
Glucotrol Glipizide Sulfonylureas 2nd generation Increases insulin production in the pancreas
Amaryl Glimepiride Sulfonylureas 2nd generation Increases insulin production in the pancreas
Orinase Tolbutamide Sulfonylureas 1st generation
 Increases insulin production in the pancreas.
Diabinese Chlorpropamide Sulfonylureas 1st generation
 Increases insulin production in the pancreas

Tolinase		 Tolazamide Sulfonylureas 1st generation
 Increases insulin production in the pancreas
Prandin Repaglinide Meglitinides Stimulates the pancreas to release more insulin but more rapidly after eating than sulfonyureas.
Starlix Nateglinide Meglitinides Stimulates the pancreas to release more insulin but more rapidly after eating than sulfonyureas.
Actos Pioglitazone Thiazolidinediones Increases insulin sensitivity and helps improve some levels of blood fat.
Avandia Rosiglitazone Thiazolidinediones Increases insulin sensitivity and helps improve some levels of blood fat.
Glucophage Metformin Biguanides Increases insulin sensitivity, keeps liver from releasing too much glucose, and improves some levels of blood fat.
Insulins:
Brand Name Generic Name Drug Category/Class Starts Working Works Best
Novolin R., Humulin R Regular Rapid Acting Insulin 0.5-1 Hour

2-5 Hours
Humalog Lispro Rapid Acting Insulin 15-20 Minutes 05-2.5 Hours
Novolog Aspart Rapid Acting Insulin 10-20 Minutes 1-3 Hours
Novolin N, Humulin N NPH Intermediate Acting Insulin

1-1.5 Hours

4-15 Hours
Novolin L, Humulin L Lente Intermediate Acting Insulin 1-1.5 Hours 4-15 Hours
Lantus Glargine Long Acting Insulin 1 Hour 2-20 Hours
Humulin U Ultralente Long Acting Insulin 4-6 Hours 8-20 Hours

 Source:DoD/VA Clinical Practice Guidelines
American Diabetes Association
National Institues of Health
Created: April 18, 2007